Cognex Corporation: Daiwa Capital Markets cuts target price to $56 from $76
CGNX•Daiwa Capital Markets cut its target price for Cognex Corporation to $56 from $76.
Related News
Xilio Therapeutics Q3 2026 net loss narrows 63% to $5.95 million
XLO•
Sionna Therapeutics posts higher-than-expected Q3 net loss on restructuring costs
SION•
Protalix presents PRX-115 Phase 2 gout trial update, expects top-line data in second half of 2027
PLX•
Ambiq Micro Q3 sales jump 110%, beat estimates on edge AI demand
AMBQ•
Olema Pharma Q3 net loss widens on higher costs
OLMA•